Back to results
US 2021/0277040 A1Published application
Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof
AssigneeBold Therapeutics, Inc.
InventorsTomas Vojkovsky, Kevin Sill, Adam Carie
Life of this patent
Estimating the term…
Abstract
The present invention relates to the preparation of compositions comprising sodium trans-[tetrachlorobis(1H-indazole)ruthenate (III)]. Synthesis and formulation preparation is detailed. Impurity profiles are also discussed. Compositions herein are useful for anti-cancer applications.
Claims13
A compound of Formula I-a:
A composition comprising sodium trans-[tetrachlorobis(1H-indazole)ruthenate (III)], sodium citrate, citric acid, and mannitol.
Dependencies are inferred from the claim text.